Lonamo Duo

Lonamo Duo combines Metformin Hydrochloride and Sitagliptin Hydrochloride Monohydrate for oral use, offering a dual-action approach to managing blood sugar levels. This medication is designed to support individuals with type 2 diabetes in maintaining glycemic control.

Lonamo Duo is primarily used to help manage type 2 diabetes by improving blood sugar control. It combines two active ingredients: Metformin Hydrochloride, which helps reduce glucose production in the liver, and Sitagliptin Hydrochloride Monohydrate, which enhances the body's natural insulin response. This dual-action approach is often recommended for individuals who require additional support beyond diet and exercise alone.

Common effects of Lonamo Duo may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Lonamo Duo should be handled with care, especially for individuals with certain medical conditions such as kidney or liver issues. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Regular monitoring of blood sugar levels is also recommended to ensure the medication's effectiveness and safety.

Lonamo Duo may interact with certain medications, including other diabetes treatments, antibiotics, and medications that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be limited, as it can affect blood sugar levels and exacerbate side effects.